Market Tracker

12/06 4:46pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

39.48
Delayed Data
As of 3:59pm ET
 +2.24 / +6.02%
Today’s Change
11.57
Today|||52-Week Range
40.30
+12.80%
Year-to-Date
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Dec 04 / MotleyFool.com - Paid Partner Content
GW Pharmaceuticals (GWPH): What Awaits in Q4 Earnings?
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.24
Today’s open36.93
Day’s range36.51 - 40.30
Volume2,190,593
Average volume (3 months)2,942,798
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+8.26%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.75

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.05-0.57%
AXONAxovant Sciences Ltd+0.31+2.21%
TBPHTheravance Biopharma...+1.47+5.06%
OPHTOphthotech Corp-1.40-3.67%
Data as of 4:02pm ET, 12/06/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts